6 results
Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance
#cirrhosis #assessment
Assessment and management ... years: summary of NICE ... #hepatitis #NICE ... #hepatology #primarycare ... #bmj
Faltering growth in children: summary of NICE guidance #Screening #Management #Peds #PrimaryCare #Underweight #Infants #FalteringGrowth #FailureToThrive
children: summary of NICE ... guidance #Screening ... #Management #Peds ... #PrimaryCare #Underweight ... FailureToThrive #BMJ
Monitoring people with cystic fibrosis #Screening #Management #Peds #PrimaryCare #CysticFibrosis #Screening #Annual #NICE #BMJ
cystic fibrosis #Screening ... #Management #Peds ... #PrimaryCare #CysticFibrosis ... #Screening #Annual ... #NICE #BMJ
Supporting children born early #Management #Screening #PrimaryCare #Peds #Preterm #Premature #Surveillance #Monitoring #NICE #BMJ
children born early #Management ... #Screening #PrimaryCare ... Surveillance #Monitoring #NICE ... #BMJ
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... DAAs #Antivirals #table ... treatment #hcv #medications ... infectiousdisease #hepatology ... HepC #HepatitisC #Management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Toxic injury to BM ... - Antithyroid medications ... • Epstein-Barr virus ... Anemia #oncology #hematology ... #diagnosis #management